Recent advances in CAR-T cell engineeringRuihao Huang, Xi Zhang, Xiaoping Li et al.|Journal of Hematology & Oncology|2020Cited by 403
Characteristics of acute myeloid leukemia with myelodysplasia‐related changes: A retrospective analysis in a cohort of <scp>Chinese</scp> patientsXiaoqian Xu, Xianmin Song, Jianmin Wang et al.|American Journal of Hematology|2014Cited by 56
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell TransplantRuihao Huang, Xi Zhang, Ting Chen et al.|JAMA Oncology|2023Cited by 53
Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I TrialRuihao Huang, Xi Zhang, Qin Wen et al.|Blood|2022Cited by 33
Abstract CT052: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR-T therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL)Xinxin Wang, Xi Zhang, Kun Wu et al.|Cancer Research|2020Cited by 30